License Required
Retacrit® Epoetin Alfa-epbx 2,000 U/mL Injection - Single-Dose Vial for Anemia Management
00069130510 | USAMP#72712634
container type
volume
dosage form
strength
Secure Checkout
Verified Supply Chain
Priority Fulfillment
More Information
Locked
Base Price
$317.01
CT
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- Manufactured by Pfizer Biosimilar, ensuring high-quality and reliability.
- Contains Epoetin Alfa-epbx, a biosimilar to Epogen®/Procrit®, used to treat anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in HIV patients.
- Available in a 2,000 U/mL strength for precise dosage according to medical requirements.
- Comes in a single-dose vial of 1 mL, designed for single use to ensure safety and sterility.
- Classified as a Hematopoietic Agent, it stimulates red blood cell production.
- Storage requires refrigeration to maintain its efficacy and extend shelf life.
